Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
Junshi Biosciences has received acceptance from China’sNational Medical Products Administration (NMPA) for toripalimab ...
The administration of bluetongue vaccines around the country has ramped up as farmers move to protect their herds ahead of the high-risk period. Bluetongue virus (BTV) is a disease spread by biting ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
Officials with the FDA have approvedthe first generic robenacoxib injectable (Robenacoxib Injection; Cronus Pharma Specialties) for the control of postoperative pain and inflammation in canine and ...
Xiaoping Wu and Jicheng Yang of Wanhuida Intellectual Property analyse an invalidation decision that addresses how dosage and administration features affect the inventiveness assessment of pharmaceuti ...
As NAD+ injections and IV drips trend from TikTok to the Kardashians, the science of longevity remains a work in progress. Explore the benefits, side effects, and the debate between oral precursors ...
ASC30 subcutaneous (SQ) depot formulation achieved statistically significant and clinically meaningful placebo-adjusted mean weight loss of 7.5% at week 16 after three monthly doses.
Local lidocaine injection shows a similar early anesthetic effect in adults with Ehlers-Danlos syndrome and healthy ...
Povetacicept significantly reduced proteinuria in patients with IgA nephropathy in the RAINIER trial, supporting an upcoming FDA submission.
Monoclonal antibodies are a type of biologic medication that can treat moderate to severe inflammatory bowel disease (IBD) by targeting specific inflammatory processes in your body. Your doctor might ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results